AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10386022
Drug: PVP-I nasal
RxNorm normalized name: PVP-I
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PVP-I nasal inhalation (1% PVP-I solution, 2 times/day for 2 weeks) without chronic respiratory complications
Trial: 26310513
Drug: EPO mouthwash
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO mouthwash (50 IU/ml, 15 ml four times a day)
Trial: 19567208
Drug: Docetaxel in
RxNorm normalized name: docetaxel Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel in an unlicensed sequential regimen FEC100-T
Trial: 9883434
Drug: Tretinoin gel
RxNorm normalized name: Tretinoin Gel
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin gel (0.025%)
Trial: 19922893
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of imatinib 400 mg
Trial: 11125881
Drug: Abacavir and
RxNorm normalized name: Abacavir and Lamivudine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abacavir and one protease inhibitor
Trial: 28460259
Drug: Enoxaparin 40mg
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40mg SQ daily
Trial: 28460259
Drug: Enoxaparin 60mg
RxNorm normalized name: ENOXAPARIN 60MG/0.6ML INJ
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 60mg SQ daily
Trial: 12604544
Drug: 2-day treatment
RxNorm normalized name: 30 day Acne Treatment Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-day treatment with 2 g of valacyclovir twice daily for 1 day and then 1 g of valacyclovir twice daily for 1 day
Trial: 3782679
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 1.5 to 4.5 mg epinephrine (10 to 30 inhalations)
Trial: 3066849
Drug: Ganglioside GM1
RxNorm normalized name: Ganglioside GM1
DrugBank: Ganglioside GM1 (DB16948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganglioside GM1 (100 mg) given daily by intramuscular injection for 28 days
Trial: 20724576
Drug: Rituximab with
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab with CHOP-like chemotherapy
Trial: 25824637
Drug: n-3 PUFAs
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFAs (1,140 mg of EPA + 600 mg of DHA)
Trial: 21854132
Drug: Probiotic yoghurt
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic yoghurt (100 g twice a day/week)
Trial: 16859579
Drug: Subcutaneous interleukin-2
RxNorm normalized name: Interleukin-2 aldesleukin
DrugBank: Aldesleukin (DB00041)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous interleukin-2 (IL-2) at dose level 2: 8 MIU/m2 per day, every other week for 24 weeks (n = 9)
Trial: 16859579
Drug: Subcutaneous interleukin-2
RxNorm normalized name: Interleukin-2 aldesleukin
DrugBank: Aldesleukin (DB00041)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous interleukin-2 (IL-2) at dose level 4: 8 MIU/m2 per day, weeks 1-4, 9-12, and 17-20 (n = 10)
Trial: 8694150
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate + Ranitidine 50 mg + Metoclopramide 10 mg (group RMC)
Trial: 12525442
Drug: 2 or
RxNorm normalized name: CP-2 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 or 5 mg mifepristone per day for 120 days
Trial: 8877932
Drug: Lornoxicam 4
RxNorm normalized name: lornoxicam 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam 4 mg tid
Trial: 7631635
Drug: Percentage of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percentage of male patients reporting receptive oral sex
Trial: 27492428
Drug: I-gel
RxNorm normalized name: Di-Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I-gel
Trial: 7010854
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of metoprolol plus placebo
Trial: 7010854
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of metoprolol plus 25 mg of hydrochlorothiazide
Trial: 7713100
Drug: Quinapril 20
RxNorm normalized name: quinapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 20 mg.day-1
Trial: 26499920
Drug: Systemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic therapy with oral corticosteroids and immunosuppression
Trial: 16412750
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg mifepristone
Trial: 14563968
Drug: Adjunct abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunct abciximab therapy (0.25 mg/kg bolus and 12-hour infusion of 0.125 microg x kg(‐1) x min(‐1))
Trial: 12842055
Drug: Nurse continence
RxNorm normalized name: PAD,NURSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse continence advisor therapy
Trial: 340005
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant (nicoumalone) treatment
Trial: 340005
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin calcium
Trial: 7986280
Drug: Ethyl alcohol
RxNorm normalized name: Ethyl alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethyl alcohol 0.55‐0.66 g/kg
Trial: 7986280
Drug: Blood alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Blood alcohol levels > 100 mg/100 ml
Trial: 25925842
Drug: edoxaban 60
RxNorm normalized name: edoxaban 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: edoxaban 60 mg once daily
Trial: 31296251
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (50 mg/kg) and thiamine (200 mg) administered intravenously every 12 hours for 48 hours
Trial: 2059298
Drug: CyA and
RxNorm normalized name: CyA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CyA and MP (double drug treatment)
Trial: 21256649
Drug: Nicotine nasal
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine nasal spray (3 mg)
Trial: 16356087
Drug: Subcuticular preincision
RxNorm normalized name: Precise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcuticular preincision infiltration with 10 ml of bupivacaine (0.5%)
Trial: 24401802
Drug: Adductor canal
RxNorm normalized name: Canalevia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adductor canal block (ACB) with ropivacaine 0.75%, 30 ml at time 0 and isotonic saline after 45 min
Trial: 24401802
Drug: Adductor canal
RxNorm normalized name: Canalevia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adductor canal block (ACB) with isotonic saline at time 0 and ropivacaine 0.75%, 30 ml after 45 min
Trial: 9621668
Drug: Isoflurane anesthesia
RxNorm normalized name: Isoflurane
DrugBank: Isoflurane (DB00753)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoflurane anesthesia with low dose fentanyl (8 micrograms.kg‐1)
Trial: 3773799
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E therapy (300 mg/day intramuscularly for seven days)
Trial: 11490039
Drug: Topical anesthetic
RxNorm normalized name: Topical anesthetic
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical anesthetic
Trial: 17938165
Drug: DTaP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP vaccine
Trial: 28213595
Drug: Short Cycle
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short Cycle Therapy (SCT) (5 days on: 2 days off)
Trial: 28213595
Drug: Continuous efavirenz
RxNorm normalized name: Efavirenz
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous efavirenz (EFV)-based antiretroviral therapy (CT)
Trial: 7604684
Drug: Maternal antiphospholipid
RxNorm normalized name: Egg Phospholipids
DrugBank: Egg phospholipids (DB14233)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal antiphospholipid antibodies (aPA) measured by anticardiolipin antibodies (aCL)
Trial: 2662354
Drug: Praziquantel 45
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel 45 mg daily dose
Trial: 3086359
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate 200 mg im every 2 weeks
Trial: 3086359
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate 100 mg im once a week
Trial: 1621434
Drug: IgM-anticardiolipin-antibodies in
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgM-anticardiolipin-antibodies in all groups
Trial: 20484099
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg before the intervention and 200 mg twice daily for 6 months)
Trial: 16454155
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (Aclasta®), 5 mg infusion
Trial: 21315223
Drug: VerifyNow Aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VerifyNow Aspirin Assay (Accumetrics), MEA ASPI test, MEA ADP test
Trial: 11475717
Drug: Weishu capsule
RxNorm normalized name: BENZODODECINIUM BROMIDE 0.3948 g in 420 mL / METHENAMINE 1.092 g in 420 mL EXTRACORPOREAL LIQUID [Youjie Weishi Disinfectant]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weishu capsule (WSC)
Trial: 16029524
Drug: Early invasive
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early invasive treatment
Trial: 15701213
Drug: Desloratadine syrup
RxNorm normalized name: Desloratadine
DrugBank: Desloratadine (DB00967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desloratadine syrup 1.25 mg (0.5 mg/mL) once daily for ages 2-5 years
Trial: 15701213
Drug: Desloratadine syrup
RxNorm normalized name: Desloratadine
DrugBank: Desloratadine (DB00967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desloratadine syrup 2.5 mg once daily for ages 6-11 years
Trial: 1557934
Drug: SPf66 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPf66 vaccine
Trial: 12208571
Drug: Pilocarpine 5
RxNorm normalized name: PILOCARPINE 5MG/UNT OPH,CRC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilocarpine 5 mg three times daily
Trial: 24161333
Drug: AMG 145
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 145 (PCSK9 monoclonal antibody)
Trial: 2142486
Drug: Teicoplanin therapy
RxNorm normalized name: teicoplanin
DrugBank: Teicoplanin (DB06149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin therapy
Trial: 12105117
Drug: Repeated administration
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated administration of MDMA (3,4-methylenedioxymethamphetamine)
Trial: 6689038
Drug: Calcitriol administration
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcitriol administration (0.75 micrograms every 6 hr)
Trial: 6689038
Drug: Calcitriol administration
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcitriol administration
Trial: 15480130
Drug: Combination Therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination Therapy (CT)
Trial: 15480130
Drug: Interferential Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferential Therapy (IFT)
Trial: 25893426
Drug: oral fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral fat
Trial: 23192700
Drug: Radiotherapy concurrently
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy concurrently with weekly cisplatin
Trial: 30202030
Drug: Celecoxib with
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib with TB drugs
Trial: 28596511
Drug: Alprazolam 0.5
RxNorm normalized name: alprazolam 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam 0.5 mg orally one hour before the operation (G1, G3)
Trial: 16677640
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate 100 mg/day
Trial: 9308928
Drug: Etanidazole combined
RxNorm normalized name: Tinidazole
DrugBank: Tinidazole (DB00911)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etanidazole combined with radiotherapy (2 g/m2, three times weekly for 17 doses)
Trial: 24988909
Drug: Flurbiprofen 8.75
RxNorm normalized name: flurbiprofen 8.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 8.75 mg lozenges (n=101)
Trial: 9721958
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg once daily for 3 days
Trial: 28271623
Drug: Probiotic capsule
RxNorm normalized name: GNP Probiotic Capsule
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsule (BIO-25)
Trial: 8353575
Drug: Heparinized flush
RxNorm normalized name: T8 Keto Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparinized flush solutions
Trial: 2962603
Drug: Metrizoate 350
RxNorm normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrizoate 350 mg I/ml
Trial: 8427753
Drug: Iohexol 350
RxNorm normalized name: iohexol 350 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iohexol 350 mg I/ml
Trial: 28893244
Drug: Omarigliptin 25
RxNorm normalized name: Omarigliptin
DrugBank: Omarigliptin (DB11992)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Omarigliptin 25 mg once weekly (q.w.)
Trial: 26802156
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cediranib 30 mg once daily and saracatinib 175 mg once daily (CS)
Trial: 2936564
Drug: Nafarelin acetate
RxNorm normalized name: Nafarelin Acetate
DrugBank: Nafarelin (DB00666)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nafarelin acetate 250 micrograms daily
Trial: 10947304
Drug: Misoprostol plus
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol plus any NSAID therapy
Trial: 23126367
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice (200 ml thrice daily for 4 days)
Trial: 8590144
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of 3 x 600 mg bismuth subsalicylate and 2 x 1000 mg amoxycillin
Trial: 21075163
Drug: Test vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test vaccine recipients
Trial: 29027598
Drug: Paclitaxel 80
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 80 mg/m2 plus pelareorep 3 × 10^10 TCID50
Trial: 20150283
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy (INT)
Trial: 1790313
Drug: Freeze-dried sodium
RxNorm normalized name: BLACKBERRY MESOCARP FREEZE DRIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Freeze-dried sodium phenytoin-milk formulation
Trial: 16096179
Drug: Pimecrolimus cream
RxNorm normalized name: Pimecrolimus
DrugBank: Pimecrolimus (DB00337)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pimecrolimus cream 1% applied four times daily (QID)
Trial: 11792138
Drug: Early conservative
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early conservative therapy
Trial: 22805468
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (280 mg DHA and 110 mg EPA daily)
Trial: 11469844
Drug: Preoperative administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative administration of ampiroxicam
Trial: 29606861
Drug: GFF MDI
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GFF MDI 14.4/10 μg
Trial: 9056049
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal administered 2 hours after amlodipine
Trial: 11869770
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium (DVPX) monotherapy, mean dose 882 mg qhs, mean level 80.7 mug/ml
Trial: 23176547
Drug: 30-week oral
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 30-week oral language intervention
Trial: 16338507
Drug: Albuterol nebulized
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol nebulized in heliox
Trial: 24914630
Drug: 12 mL
RxNorm normalized name: syringe, disposable, 12 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mL mepivacaine 2% (group concentration I)
Trial: 9163263
Drug: Prilocaine 650
RxNorm normalized name: Prilocaine
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prilocaine 650 mg
Trial: 1607520
Drug: Accelerated 90-min
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated 90-min regimen of rt-PA (100 mg total)
Trial: 18555937
Drug: G-ER QD
RxNorm normalized name: quinidine gluconate Extended Release Oral Tablet [Quin-G]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-ER QD (1800 mg at 8 pm)
Trial: 16776753
Drug: Moxonidine 0.2
RxNorm normalized name: moxonidine 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxonidine 0.2 mg twice daily for 16 weeks
Trial: 1433582
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (155 children)
Trial: 24120032
Drug: Energy-restricted diet
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy-restricted diet enriched in n-3 PUFAs (20 kcal/kg/ideal body weight/day, average 2.6 g/d)
Trial: 22613740
Drug: Diuretic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic treatment (spironolactone, 100 mg day(-1) for 3 days)
Trial: 11348716
Drug: Influenza vaccine
RxNorm normalized name: Influenza vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccine (administered to ambulatory clinic patients)
Trial: 11317060
Drug: Herbal medicines
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Herbal medicines
Trial: 23136538
Drug: Single-dose parecoxib
RxNorm normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Single-dose parecoxib (40mg at 30min before the end of surgery)
Trial: 16442481
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not explicitly defined, but implied as standard morphine treatment without midazolam)
Trial: 8269574
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow rates of 10.4 L.min‐1
Trial: 12670812
Drug: Intrathecal +
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal + PCA morphine (IT+PCA)
Trial: 30376884
Drug: Eplerenone 25
RxNorm normalized name: eplerenone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 25 mg every 12 hours for 4 days (first dose prior to kidney transplantation)
Trial: 9104903
Drug: Aspirin 200
RxNorm normalized name: aspirin 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 200 mg/day, ticlopidine 500 mg/day, and warfarin for 1 month (group 1)
Trial: 19770473
Drug: Telcagepant 300
RxNorm normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telcagepant 300 mg